Bionomics Ltd. is a clinical stage biopharmaceutical company. It engages in the development of novel drug candidates focused on the treatment of serious central nervous system disorders. Its lead product candidate is BNC210. The company was founded in 1996 and is headquartered in Eastwood, Australia.
Need a custom stock scraper? Want to do some machine learning? We are here to help! Reach out to us!